Skip to content

Clinical trials

Hypertension trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Country / region: New Zealand Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20061
20071
20082
20091
20123
20134
20142
20182
20211
20221
20232
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting4
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim5
Abbott Medical Devices2
Kona Medical Inc.2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Alnylam Pharmaceuticals1
Bayer1
Boston Scientific Corporation1
CSL Behring1
Children's & Women's Health Centre of British Columbia1
George Medicines PTY Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension25
Cardiovascular Diseases6
Stroke3
Acute Coronary Syndrome2
Atherosclerosis2
Diabetes Mellitus, Type 22
Kidney Failure, Chronic2
Myocardial Infarction2
Anemia1
Arteriovenous Fistula1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.